ASX:MVP FY26 ANNUAL GENERAL MEETING 12 November 2026 1 Important notice and disclaimer This presentation contains summary information about Medical Developments International Limited (ACN 106340667) and its related bodies corporate (together, MVP) and MVP’s activities as at the date of this...
2026 Annual General Meeting Presentation
Filed with ASX · · 23 pages · English
Release
Medical Developments International Limited on 6ix
In the deck
Story so far
Earlier from Medical Developments International
- 2026 Annual General Meeting Chair and CEO Address
- Change in substantial holding
- Appendix 4C and Quarterly Activity Report -30 September 2026
- CEO Transition
- Corporate Governance Statement 2026
Later from Medical Developments International
- Results of 2026 Annual General Meeting
- 2026 Annual General Meeting Recording
- Interim CEO Remuneration Update
- Ceasing to be a substantial holder
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International